ATBECHDEDKESFRGBGRITLILUNLSEMC......................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0578687A119940119EP92907543.01992033119931029enenen1991067887319910404US1991075118619910826US1991077291919911008US1994011919940319940119199403

G01N 33/ 48 A I

A61K 31/ 135 A I

A61K 31/ 137 A I

A61K 45/ 00 A I

A61P 9/ 10 A I

A61P 11/ 00 A I

A61P 21/ 02 A I

A61P 25/ 00 A I

A61P 25/ 02 A I

A61P 25/ 08 A I

A61P 25/ 16 A I

A61P 25/ 28 A I

A61P 31/ 12 A I

C12Q 1/ 02 A I

C12Q 1/ 06 A I

C12Q 1/ 26 A I

G01N 33/ 15 A I

G01N 33/ 50 A I

G01N 33/ 68 A I

enUSE OF DEPRENYL TO MAINTAIN, PREVENT LOSS, OR RECOVER NERVE CELL FUNCTIONfrUTILISATION DU DEPRENYLE POUR MAINTENIR OU RECUPERER LA FONCTION DE CELLULES NERVEUSES OU POUR EMPECHER LA PERTE DE CETTE FONCTIONdeVERWENDUNG VON DEPRENYL ZUR UNTERHALTUNG,VERHINDERUNG VON VERLUST ODER ZURÜCKGEWINNUNG VON NERVENZELLEFUNKTION03029904.41413299THE UNIVERSITY OF TORONTO INNOVATIONS FOUNDATIONCrédit Suisse Building, 525 University Avenue, Suite 925Toronto, Ontario M5G 2L3CATATTON, William, G.976 Silver Birch TrailMississauga, Ontario L5J 4S3CAGREENWOOD, Carol, E.187 Bain AvenueToronto, Ontario M4K 1E9CAWest, Alan HarryR.G.C. Jenkins & Co. 26 Caxton StreetLondon SW1H 0RJGBATBECHDEDKESFRGBGRITLILUMCNLSECA199200013319920331enWO199201716919921015199226